FIORICET W Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fioricet W, and when can generic versions of Fioricet W launch?
Fioricet W is a drug marketed by Actavis Labs Ut Inc and is included in one NDA.
The generic ingredient in FIORICET W is acetaminophen; butalbital; caffeine; codeine phosphate. There are sixty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine; codeine phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FIORICET W?
- What are the global sales for FIORICET W?
- What is Average Wholesale Price for FIORICET W?
Summary for FIORICET W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | FIORICET W at DailyMed |
US Patents and Regulatory Information for FIORICET W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Ut Inc | FIORICET W/ CODEINE | acetaminophen; butalbital; caffeine; codeine phosphate | CAPSULE;ORAL | 020232-001 | Jul 30, 1992 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
